Quick Answer
L-Carnitine Exercise Recovery Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: The results of a prior study confirmed the protective benefits of L-carnitine due to suppression of inflammation, oxidative stress, and increased autophagy (Khedr and Werida).
Key Takeaways
- 01The results of a prior study confirmed the protective benefits of L-carnitine due to suppression of inflammation, oxidative stress, and increased autophagy (Khedr and Werida). [Werida Rehab H. (2026)]
- 02Several experimental and clinical studies have suggested that L-carnitine supplementation may confer cardiovascular benefits in CAD patients, including improved cardiac metabolism, reduced oxidative stress, attenuation of inflammatory responses, and enhanced functional outcomes (Da Silva Guimarães et al.; Dastan et al.; Lee et al.; Lee et al.; Pastoris et al.; Singhai et al.; Tarantini et al.; Xue et al.). [Werida Rehab H. (2026)]
- 03To our best knowledge, this is the first systematic review to address these gaps by synthesizing evidence in CAD patients across mechanistic markers such as oxidative stress, inflammatory mediators, autophagy-related markers and post-PCI myocardial-injury biomarkers together with clinical endpoints such as ventricular arrythmia, mortality and angina. [Werida Rehab H. (2026)]
- 042019 2019 2015 Cardiovascular disease (CVD) is the predominant cause of death worldwide, with a substantial proportion attributable to ischemic heart disease, caused by atherosclerotic coronary artery disease (CAD) (Glovaci et al.; Sarrafzadegan and Mohammadifard). [Werida Rehab H. (2026)]
The current Migaku evidence database contains 2 reusable source documents for L-Carnitine Exercise Recovery Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- The results of a prior study confirmed the protective benefits of L-carnitine due to suppression of inflammation, oxidative stress, and increased autophagy (Khedr and Werida). [Werida Rehab H. (2026); evidence level 1]
- Several experimental and clinical studies have suggested that L-carnitine supplementation may confer cardiovascular benefits in CAD patients, including improved cardiac metabolism, reduced oxidative stress, attenuation of inflammatory responses, and enhanced functional outcomes (Da Silva Guimarães et al.; Dastan et al.; Lee et al.; Lee et al.; Pastoris et al.; Singhai et al.; Tarantini et al.; Xue et al.). [Werida Rehab H. (2026); evidence level 1]
- To our best knowledge, this is the first systematic review to address these gaps by synthesizing evidence in CAD patients across mechanistic markers such as oxidative stress, inflammatory mediators, autophagy-related markers and post-PCI myocardial-injury biomarkers together with clinical endpoints such as ventricular arrythmia, mortality and angina. [Werida Rehab H. (2026); evidence level 1]
- 2019 2019 2015 Cardiovascular disease (CVD) is the predominant cause of death worldwide, with a substantial proportion attributable to ischemic heart disease, caused by atherosclerotic coronary artery disease (CAD) (Glovaci et al.; Sarrafzadegan and Mohammadifard). [Werida Rehab H. (2026); evidence level 1]
- Aging is closely associated with oxidative stress, mitochondrial dysfunction, chronic inflammation, and progressive declines in muscle and cognitive function. [Wang X (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources